|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 1632232 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05108086.9 |
| Date of filing the European patent application | 2005-09-02 | |
| (97) | Date of publication of the European application | 2006-03-08 |
| (45) | Date of publication and mention of the grant of the patent | 2011-05-11 |
| (46) | Date of publication of the claims translation | 2011-09-26 |
| (30) | Number | Date | Country code |
| 0403578 | 2004-09-02 | MY | |
| 05101467 | 2005-02-25 | EP | |
| PCT/US2004/0145 | 2004-09-03 | WO |
| (72) |
Stevens, Paul, Theodoor, Agnes, BE
Peeters, Jozef, BE
Vandecruys, Roger, Petrus, Gerebern, BE
Stappers, Alfred, Elisabeth, BE
Copmans, Alex, Herman, BE
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | 4[[4-[[4-(2-cianoetenil)-2,6-dimetiIfenil]amino]-2-pirimidinil]amino]benzonitrilo druska |
| Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile |
| Payment date | Validity (years) | Amount | |
| 2024-08-07 | 347.00 EUR |